Flavonoids are not essential nutrients in that their absence from the diet does not produce deficiency conditions in animals and man. However, many have important similarities to pharmacological agents used in the treatment of disease. Their role as dietary components in disease prevention is less clear. Many potentially anti-carcinogenic and anti-atherogenic effects observed in cell cultures will not be of nutritional relevance unless flavonoids gain access to appropriate cellular sites. The bioavailability of flavonoids will depend on numerous factors including molecular structure, the amount consumed, the food matrix, degree of bioconversion in the gut and tissues, the nutrient status of the host and genetic factors. Moreover, extensive and rapid intestinal and hepatic metabolism of flavonoids suggests that the body may treat them as xenobiotic and potentially toxic compounds requiring rapid elimination. Consequently, in addition to potential health benefits, possible adverse effects of flavonoids in the diet also need to be considered when assessing their roles in the prevention of degenerative diseases.
Ischaemic heart disease, cancer, and stroke are major causes of morbidity and premature mortality. A major contributing factor to the aetiology of these chronic diseases is a poor diet [1] . Numerous epidemiological studies indicate that diets rich in plant-based products such as fruit, vegetables, teas and wine provide protection against the development of these major diseases [2, 3] . Over the years, such protective effects have been equivocally ascribed to dietary plant components such as fiber, antioxidant vitamins, trace elements and plant lipids. However, plants also contain more than 100,000 secondary metabolites [4] of which the flavonoids are one of the most widely distributed groups [5] . Consequently, their role in diet and health has been amongst the most extensively investigated to date. Numerous in vitro studies indicate that many flavonoids can potentially affect diverse processes in mammalian cells, which, if also occurring in vivo, could have beneficial or detrimental consequences for health. These processes include gene expression, apoptosis, platelet aggregation, LDL oxidation, blood vessel dilation, intercellular signalling, P-glycoprotein activation, inflammation and the modulation of enzyme activities associated with carcinogen activation and detoxification [6] . As such compounds are likely to be present in a wide range of fruit, vegetables, beverages, herbs and spices of dietary relevance, this article discusses whether these secondary metabolites have a role in disease prevention from a nutritional perspective. This requires understanding of which types of plant based foods are the richest sources, whether they are released from the food matrix on ingestion, their metabolic fate and mechanism(s) of action of the parent compound or resulting metabolites in mammalian cells.
Origins and types of flavonoids in foods
Flavonoids are synthesized through the highly branched phenylpropanoid pathway. Ascribing nutritional importance to flavonoids is confounded by the sheer number present in plants and their ability to form associated structures with a range of other molecules. Over 4,000 individual compounds have been identified and subdivided into twelve subclasses [7] . Dietary research to date has primarily focused on flavonoids with a characteristic 3-ring flavone nucleus (C6-C3-C6), consisting of 2 aromatic rings linked through an oxygen-containing cyclized heterocyclic ring. Consequently, this review will focus on flavonoids of this nature which include flavanones, isoflavones, flavones, flavonols, anthocyanidins, and flavan-3-ols (catechins). However, aglycones are rarely found in foods. Flavonol, flavone and anthocyanidin aglycones can be glycosylated, methylated, and/or acetylated at hydroxyl sites on their structure primarily at positions 3, 5 and 7. These compounds are often found in foods as O-glycosides with D-glucose being the most common conjugated carbohydrate. Galactose, rhamnose, xylose and arabinose conjugates also occur with decreasing frequency. Sugars attached directly to the flavonoid can be further glycosylated yielding di-saccharides, tri-saccharides and even tetra-saccharides.
With the exception of anthocyanins, flavonoid aglycones are lipophilic though glycosylation makes them weakly hydrophilic. Sugar moieties directly attached to flavonoid aglycones provide the binding sites for acylation with, for example, aromatic acids such as hydroxycinnamic acids and aliphatic acids, including malonic acid. However, catechins in edible plants are rarely either glycosylated or methylated, but can be esterified with gallic acid. Some food sources of dietary flavonoids are given in Table 1 and [8] . Values are mg aglycone/kg. A more comprehensive assessment of 5 classes of flavonoid in commonly available foods, which is derived from critically assessed published sources using evaluation procedures which ensure the inclusion of content values for edible parts of plant materials available to the UK consumer, can be found in [8] .
Dietary intake of flavonoids
The diversity of form of flavonoids in foods and the fact that concentrations can vary by many orders of magnitude and are influenced by several factors including species, variety, light, degree of ripeness, processing and storage [9] makes accurate determination of dietary intakes distinctly problematical. An initial estimate of flavonoid intake of 1000 mg per day was calculated in the USA during the 1970s using semi-quantitative food composition data [10] . This estimate was not questioned until the 1990s with the calculation of dietary flavonol and flavone aglycone (including glycosides hydrolyzed to their free form) intake from Dutch composition data for 28 vegetables, 9 fruits and several beverages [11, 12] . When the data in [10] , originally expressed as quercetin-3-rhamnoside equivalents, are converted to quercetin aglycones (703-738 mg/day), flavanones, flavonols and flavones contribute 110-121mg/day. This suggests that the earlier study somewhat overestimated dietary flavonoid intake.
Several dietary flavonoid intake studies ( Table 2) have now been completed using the Dutch composition data, often with additional estimates of flavonoid content of local food preferences, such as berries. Comparison of these intake studies indicates that quercetin is consistently the main contributor to flavonol and flavone intake. In the Netherlands for example, quercetin accounts for 70% of the 23 mg per day total flavonol and flavone intake, followed by kaempferol (17%), myricetin (6%), luteolin (4%) and apigenin (3%) [13] . Different countries obtain flavonoids from differing sources with, for example, green tea being the main contributor to intake in Japan, red wine in Italy and apples in Finland [14] . 
Potential mechanisms of action in disease prevention
Flavonoids have been reported to have diverse effects on many aspects of mammalian cell metabolism and homeostasis. However, it is important to note that most of these effects have been observed using cellular and animal model systems and that concentrations used in such studies are often nonphysiological. Until analogous studies are conducted on human volunteers using nutritionally relevant concentrations, potentially beneficial actions of dietary flavonoids will not be clearly established.
(a) Flavonoids as antioxidants:
Free radical mediated oxidation of proteins, lipids and DNA is implicated in the pathogenesis of many diseases including heart disease and cancers [20] . Many flavonoids are effective free radical scavengers in a wide range of chemical oxidation systems [21] , their reaction stoichiometry often exceeding that of recognized nutritional antioxidants such as vitamin E.
Catechins and flavonols readily scavenge superoxide, hydroxyl radicals, peroxyl radicals and peroxynitrite in chemical model systems [22] [23] [24] [25] [26] [27] . Their ability to act as antioxidants is influenced by the number and position of hydroxyl groups (-OH), the presence of an unsaturated 2,3 double bond in the heterocyclic C-ring and the type and position of conjugation molecules. Catechins demonstrate the strongest radical scavenging ability of the flavonoids in both lipid and water soluble systems. Gallic acid esters of catechin, such as (-)-epigallocatechin gallate have eight free -OH donors, while (-)-epicatechin possesses only five. The effect of polymerization on the antioxidant activity of catechins is unclear, as proanthocyanidins have received less attention than their monomeric counterparts. However, proanthocyanin-rich extracts from wine and tea, for example, have demonstrated potent superoxide and singlet oxygen quenching abilities [28] . Flavones lack a hydroxyl group in the C-ring of the flavan nucleus while anthocyanins possess two unsaturated double bonds in the C-ring. Both of these subclasses demonstrate relatively low radical scavenging abilities.
Flavonoids also chelate transition metal ions such as iron and copper, which have a major role in producing highly reactive hydroxyl radicals through Fenton reactions [28] [29] [30] [31] [32] . Chelation of these metals can also prevent the formation of alkoxyl radicals, which can propagate lipid peroxidation chain reactions.
Antioxidant activity of flavonoids has also been demonstrated in cell model systems, as judged by the ability to decrease markers of oxidation to lipids [34] , proteins [35] and DNA [36] . For example, flavonols can significantly reduce DNA strand breakage and oxidized pyrimidine levels in hydrogen peroxide stressed lymphocytes [37, 38] .
In addition, antioxidant effectiveness has been demonstrated in vivo in several animal feeding studies [39] [40] [41] [42] [43] [44] . For example, treatment of rats with G-rutin (containing flavonol glycosides) for 18 days leads to significantly reduced liver protein carbonyls (marker of oxidative protein damage) and urinary excretion of thymine and thymidine glycols (indices of DNA base damage) [45] .
Flavonoids may also participate in synergistic interactions with vitamin C, tocopherols and β-carotene by recycling the oxidized forms to their reduced state [39] . For example, consumption of catechin-rich green tea for 4 weeks preserved tocopherols and β-carotene, resulting in protection of red blood cell membrane polyunsaturated fatty acids [46] . Flavonoids can also either spare or enhance the effects of endogenous antioxidant enzymes, including glutathione peroxidase, glutathione reductase, superoxide dismutase and catalase in cellular and animal model systems [47] [48] [49] [50] . However, such observations have not been consistently replicated in humans [51] .
The antioxidant effect of flavonoid compounds may be biphasic. At high concentrations they may act as pro-oxidants either by auto-oxidation or the reduction of metal ions, leading to the production of free radicals such as hydroxyl radicals and hydrogen peroxide, which can result in either oxidative DNA damage or generation of lipid peroxides. However, evidence for pro-oxidant effects in vivo generally is lacking [52] .
(b) Anti-inflammatory actions:
Uncontrolled chronic inflammation is now believed to be a causative factor in many diseases including cardiovascular disease and several cancers [53] . Flavonoids may have antiinflammatory activity influencing eicosanoid production and immune function through leukocyte activation promoting the release of inflammatory mediators (e.g. cytokines) [54] . This may be mediated through the inhibition of key regulatory enzymes involved in the activation of prostaglandins and leukotrienes. For example, modulation of prostaglandin and thromboxin responses occurs through inhibition of lipoxygenase and cycloxygenase pathways and these are inhibited in vitro by some flavonoids, such as quercetin [55, 56] , but not others. As with antioxidant activity, such anti-inflammatory effects appear to be dependent on molecular structure.
Flavonol glucosides and catechins may also reduce inflammation by suppressing pro-inflammatory factors including TNFα and interleukins (IL) [57] [58] [59] . This would subsequently prevent the up-regulation of various inflammatory mediators including IL8, MCP-1 and ICAM-1 that are involved in the recruitment of leukocytes to sites of damage or inflammation [60] . For example, cocoa procyanidins inhibited IL, thus modulating T-cell proliferation, and low concentrations (<1µM) of luteolin aglycones and the -7-glucoside inhibit the release of TNFα and IL-6 of lipopolysaccharide stimulated macrophages [61] .
(c) Modulation of signalling pathways:
The cellular and animal evidence supporting a direct anti-oxidant and anti-inflammatory role of flavonoids has proved evasive when tested in humans [62] . Several reasons for this lack of definitive evidence have been muted, including their relatively low bioavailability with high nanomolar concentrations after feeding microgram doses. Other potential antioxidants such as vitamin C and vitamin E, in comparison, are frequently found circulating at micromolar levels in a form capable of exerting antioxidant power in humans. Interestingly, neuronal cell death following up-take of oxidized low density lipoprotein was found to be more efficiently minimized by low concentrations of flavonoids than by ascorbate [63] . These observations may indicate that flavonoid action may be subtle and indirect [64] [65] [66] . Flavonoids and more recently their metabolites, when tested in cell-culture and transgenic animal model systems, have demonstrated abilities to activate cell-signalling cascades and modulate gene expression. For example, the tea flavonoids, such as epigallocatechin gallate, has both inhibitory and activatory capability within the mitogen protein kinase (MAP) signalling pathway [67] and can phosphorylate specific protein kinases, including activity inhibitor κβ (Iκβ) kinase. This subsequently reduces expression of transcription factors, including activator protein 1 (AP-1) and nuclear factor κβ (NFκβ)
Flavonoids and heart disease
Ischaemic heart disease (coronary heart disease, CHD) and cerebral ischaemia are secondary conditions of atherosclerosis, a term used to describe thickening of the internal walls of arteries. Atherosclerosis is possibly initiated by injury or inflammation to arterial endothelial cells [68] . This causes the release of growth factors, which stimulate platelet aggregation, and the migration of monocytes and T-lymphocytes to the arterial wall. After crossing the endothelium and accumulating in the subendothelial space of the vascular wall, the monocytes are subsequently transformed into macrophages. These tend to accumulate low density lipoproteins, which contain cholesterol esters, leading to formation of "foam cells", which together with the T-lymphocytes and arterial smooth muscles cells form "fatty streaks", which develop into "fibrofatty lesions" and then into "fibrous plaques". Such plaques can become calcified, producing an "atheromatous plaque", which results in narrowing of the artery. These are prone to rupture and subsequent release of their contents into the blood stream leads to platelet aggregation, resulting in "occlusive thrombosis". The above process is exacerbated if LDL is low in antioxidants and therefore more susceptible to oxidation. This is because, in contrast to native LDL, the oxidised form is preferentially and rapidly taken up by macrophages [69] . Oxidised LDL is also cytotoxic and thus may also contribute to local endothelial injury, thus further promoting the development of more fatty streaks [70] .
A role for flavonoids protecting against coronary heart disease and stroke is supported by numerous cellular and animal studies and limited human supplementation trials. These investigations essentially suggest that these plant secondary metabolites can moderate the diverse range of pro-atherosclerotic events during the development and progression of the disease (Figure 1 ).
For example, isolated flavonols and catechins and flavonoid-rich foods, such as red wine, apple, tea and pomegranate juice are reported to decrease LDL oxidation by metal ions, such as copper and iron [ [71] [72] [73] [74] [75] [76] [77] in vitro and in vivo. Additionally, accumulation of oxidised LDL esters in damaged endothelial cells and macrophages and modified lipid profiles have been demonstrated in animals fed flavonoid rich diets [78] [79] [80] . Such effects may be due to the direct scavenging by flavonoids of oxidising species or by their ability to bind LDL protein and promote aggregation of LDL, thus reducing surface area available for oxidation. Some studies with human subjects indicate that the susceptibility of LDL in plasma to oxidation is reduced after consuming flavonoid-rich beverages and extracts [81] [82] [83] [84] . However, other studies have failed to detect similar changes [85] [86] [87] [88] [89] . The reasons for the disparity between studies is unclear, but may reflect the type of flavonoid used, differences in intervention protocol or differences in the antioxidant status and absorption kinetics of volunteers.
Flavonoids may also exert protective effects that do not necessarily invoke their antioxidant properties. These include inhibiting platelet adhesion and aggregation by modulating the cycloxygenase pathway and reducing the cyclic 3'5'-adenosine monophosphate response of platelets to prostaglandin I 2 [90] [91] [92] [93] . Vasodilatory effects due to enhanced nitric oxide generation, cyclic guanosine 3'5'-monophosphate accumulation and other endothelium-dependant relaxation factors have also been reported [94] [95] [96] [97] [98] Epidemiologically, the association between high dietary flavonoid intake and reduced risk of mortality from coronary heat disease was initially muted in the early 1990s [99] . Generally the findings from subsequent studies have been inconsistent (Table 3) Additionally, no association has been found between stroke risk and flavonol, flavone or catechin intake [109] [110] [111] [112] . While reduced risk of developing intermittent claudication has been weakly linked with high flavonoid intake in a cohort of male smokers, intake was not independent of other antioxidants or vegetable consumption [113] . This observation highlights a more consistent finding that consumption of flavonoid rich foods such as tea, broccoli and onions, and red wine have more frequently been linked with reduced risk of ischaemic disorders suggesting that a complex mixture of nutrients and secondary plant metabolites is required to obtain beneficial effects from plant based foods. The equivocal nature of the epidemiological evidence may also be a consequence of the limited, but highly variable, food flavonoid composition data.
Flavonoids and cancer
Cancer is a group of diseases with a common defect; essentially control of normal cell growth and replication is disturbed. There is considerable evidence that carcinogenesis is a multistage process, which can be initiated and modulated by chemical agents present in the environment such as those found in the diet, ultraviolet radiation and tobacco smoke. Cancer has complex aetiology but essentially there are three distinct steps in carcinogenesis; initiation, promotion (preneoplastic) and progression (neoplastic) In the initiation phase, cellular DNA is damaged disturbing the cell cycle and leading to the activation of proto-oncogenes. In the promotion phase, selective cell proliferation is stimulated, possibly due to the activation of cellular receptors, which are involved in growth control or by inhibition of intracellular communications. Benign cellular growth is accelerated, enhancing the risk of mutations and inhibiting tumor suppressor genes.
There are numerous potential anti-carcinogenic effects of flavonoids ( Figure 2 ). For example, through their antioxidant activity, flavonoids may exert anticarcinogenic effects by preventing oxidative DNA damage, at least in cell culture systems [114] . Analogous protective effects had been reported ex vivo with, for example, a 20% increase in the ability of plasma to inhibit free radical-induced DNA damage to lymphocytes being observed 1 hour after the consumption of 300 mL of flavonoid-rich wine [115] . However, results from intervention trials with flavonol aglycones assessing lymphocyte DNA strand breakage ex vivo have been contradictory [116] .
Flavonoids may also modulate enzyme systems controlling carcinogen metabolism and detoxification. For example, both in vitro and animal model studies indicate that flavonoids modulate phase I and II cytochrome P450 enzymes, which conjugate highly reactive and potentially carcinogenic metabolites [117] . Regulation of gene expression, transcription and the cell cycle [118] can also be affected by flavonoids, thus, for example, suppressing accelerated proliferation of neoplastic cells. Flavonoids may also possess some estrogenic activity, which has been postulated to protect against hormonally linked breast and prostate cancers [119] [120] [121] [122] .
Despite considerable experimental evidence that some flavonoids have potent anticarcinogenic activity, the epidemiological evidence is weak. For example, several cohort studies have failed to show clear significant statistical associations between intakes of flavonols, flavones and catechins and several types of cancer, including breast, kidney, prostate and stomach. [123] [124] [125] [126] [127] [128] .
The importance of bioavailability
There is a disparity between experimental data indicating potent anticarcinogenic and atherogenic activity of flavonoids and results from epidemiological and human intervention studies, which generally fail to show protective effects. It is important to note that most of these effects have been observed using cellular and animal model systems and that concentrations used in such studies are often greater than can be achieved from diet alone. Saturation of metabolic pathways by "pharmacological" doses, appear to be required to obtain the free form in the blood.
Early studies suggested that flavonoid glycosides present in food were not absorbed intact from the diet, prior hydrolysis by digestive enzymes such as ß-glycosidases being required to liberate the aglycone [10] . In contrast, more recent studies with ileostomy patients [129, 130] concluded that flavonoid glucosides were more bioavailable than the aglycones and that the small intestine was a major site of absorption. Estimates of flavonoid absorption now range from 0 to 50%, factors influencing uptake including molecular weight and the degree and type of glycosylation and esterification. A tentative model for predicting the absorption of flavonoids by humans has been proposed [131] based on available literature (Figure 3 ).
For example, as the aglycone of quercetin has a low solubility compared with its monoglucoside, it is predicted to be poorly absorbed through the lining of the small intestine. However, absorption of quercetin glucosides can occur from the small intestine either actively via sugar transporter mechanisms (the sodium glucose transporter) or passively following deconjugation and/or glucuronidation by lactase phlorizin hydrolase (LPH) and cytosolic βglucoside (CBG). However, rhamnosides, such as rutin (quercetin rhamnoglucoside), pass into the colon unabsorbed.
Once absorbed, flavonoids are then likely to be rapidly transferred to the liver where they are metabolized. The extent and identity of these in vivo metabolites is still poorly understood. It is, however, clear that in most instances once flavonoids enter the circulatory system there is rapid and extensive hepatic metabolism of the parent flavonol glucosides involving deglycosylation, glucuronidation, sulfation and methylation reactions [131] . Thereafter, metabolized flavonoids appear to follow three possible routes. They may be excreted in the bile and transferred back to the small intestine, transferred to the renal system and possibly further methylated before being excreted in the urine or released into the circulatory system and distributed to tissues probably bound to albumin [132] .
Those flavonoids passing into the colon either unabsorbed or excreted in the bile are metabolized by intestinal bacteria such as Bacteroides distansonis that excrete rhamnosidases and glucosidases. Hesperidin, for example, can be enzymatically hydrolyzed to the aglycone, hesperetin, and then further degraded by splitting the heterocyclic C-ring to derivatives including 2,4-dihydroxyphenylacetic acid, simple phenolic acids and carbon dioxide [133] . These liberated aglycones and degradation products, such as phenyl acetic acids and phenylpropionic acids can then either be reabsorbed from the colon [134, 135] or excreted in the faeces [135, 136] .
Conclusion
Flavonoids are ubiquitous in plant based foods and considerable in vitro evidence suggests that many have a range of potential anti-cancer and heart disease properties, including antioxidant, antiinflammatory, and cell regulatory effects. However, many flavonoids appear to be rapidly metabolized in vivo suggesting that the body may be treating them as xenobiotics. Information is only beginning to emerge on the levels and identity of the numerous in vivo metabolites that appear in the circulatory system after ingestion of flavonoid rich foods. Consequently, future studies investigating the potential health benefits of flavonoids need to use genuine in vivo metabolites rather than the aglycones or glycosides, which do not appear to accumulate in the body. 
